Keyphrases
Acute Confusional State
31%
Adverse Drug Reaction
100%
Adverse Effects
8%
Behavioral Disorders
7%
Carbapenems
7%
Clinical Characteristics
8%
Clinical Evidence
13%
Clinical Judgment
7%
Clinical Response
8%
Complete Response
17%
Creatinine Clearance
23%
Cutaneous Lupus Erythematosus
8%
Disease Activity
31%
Educational Activities
12%
Educational Session
31%
Ertapenem
31%
Extrarenal
31%
Fatal Outcome
7%
Feedback Sessions
12%
Hospital Outpatient Clinics
31%
Hospital Physicians
13%
Hypoalbuminemia
7%
Inappropriate Treatment
7%
Joint Involvement
8%
Medical Specialities
11%
Multicentric
31%
Neurological Manifestations
8%
Neurotoxic Effects
31%
Neurotoxicity
15%
Off-label Use
62%
Outpatient Treatment
31%
Partial Response
17%
Patient Characteristics
10%
Patient Prognosis
7%
Patient Register
35%
Pharmacodynamic Properties
7%
Pharmacokinetic Properties
7%
Pharmacovigilance
36%
Pharmacovigilance System
14%
Physician Opinion
12%
Relevant Changes
7%
Renal Failure
7%
Renal Function
7%
Rituximab
35%
Severe Disease
31%
SLE Disease Activity Index (SLEDAI)
8%
Spontaneous Reporting
41%
Systemic Lupus Erythematosus
31%
Teaching Hospital
14%
Thrombocytopenia
17%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Drug Reaction
100%
Adverse Event
25%
Behavior Disorder
7%
Carbapenem
7%
Clinical Trial
10%
Clostridium Botulinum Type A
10%
Confusion
31%
Creatinine
23%
Diarrhea
7%
Disease
31%
Disease Activity
31%
Drug Toxicity
6%
Ertapenem
31%
Fatality
7%
Hypoalbuminemia
7%
Moderate Renal Impairment
7%
Neurotoxicity
15%
Off-Label Use
62%
Omalizumab
10%
Pharmacodynamics
7%
Pharmacokinetics
7%
Pharmacotherapy
6%
Pharmacovigilance
55%
Prospective Cohort Study
10%
Prospective Study
31%
Remission
8%
Retrospective Study
62%
Rituximab
41%
Systemic Lupus Erythematosus
31%
Thrombocytopenia
17%
Medicine and Dentistry
Adverse Drug Reaction
31%
Health Care Cost
13%
Hospital
31%
Human Immunoglobulin
31%
Immune Deficiency
6%
Immunoglobulin
31%
Patient
24%